Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains
Antheia CEO and co-founder Christina Smolke shared how synthetic biology can help solve pressing pharma challenges during the 2022 CPHI...
Search
Antheia
- Aug 25
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing
Dive into DSP in the final edition of our Demystifying SynBio series. If you’re just joining us, be sure to catch up on parts I, II, III,...
Antheia
- Aug 16
Introducing Guerin Kob, Antheia’s VP of Supply Chain
With a pilot plant on the horizon and a pipeline filled with promise, Antheia is poised to soon establish a fermentation-based supply...
Antheia
- Jul 18
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development
Learn more about synbio and the tools and technologies advancing this field in Part I, Part II, and Part III of this blog series....
Antheia
- Jun 12
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology
Just joining us? Check out Part I and Part II of the series. Synthetic biology is often touted as a software-driven and...
Antheia
- Jun 6
Introducing CPO Heidi Pucel
Growth and change can be challenging within dynamic, evolving startups, but it’s easier to navigate when you are tuned in to how people...
Antheia
- Apr 13
Demystifying Synthetic Biology II: Molecular Biology Advancements Enabling Synthetic Biology
Just joining us? Start with part one of our demystifying synthetic biology series. Synthetic biology seems like a brand-new, precision...
Antheia
- Feb 9
Demystifying Synthetic Biology: Building with the power of biology
Technology today is defined by superlatives: we have the fastest cars, the best medicine, and the most advanced communication tools ever...
Antheia
- Dec 10, 2021
Introducing Zack McGahey, Antheia’s COO
Antheia is at a critical point in scaling our production technology. Just as we bring together exceptional science and technologies to...
Christina Smolke
- Oct 12, 2021
Join the Movement to Build a Century-Defining Technology
Synthetic biology isn’t a household name - yet. But it will be soon, because it’s a thriving, innovative field that’s solving some of...
Antheia
- Apr 6, 2021
Fixing essential medicine shortages: obstacles and opportunities
Global health experts and governing bodies agree that everyone has a right to access the medicines they need. The COVID-19 pandemic and...
Kristy Hawkins
- Mar 22, 2021
Investing in the next wave of biomanufacturing technologies for pharma
The global pandemic has brought pharmaceutical manufacturing to the forefront of America’s public consciousness. Acute drug shortages...
Antheia
- Feb 4, 2021
Meet the Team - Our Lab Operations Team
For the final installation in our “Meet the Team” series, we hear from Olivia, Khurram and Vicky, who lead our operations. This team is...
Kristy Hawkins
- Jan 12, 2021
Scaling synthetic biology as a manufacturing platform
How Antheia is reaching commercial scale with plant-inspired pharmaceuticals
Antheia
- Dec 17, 2020
Meet the Team - Our Engineer, Yuki Higa
For the next installation in the “Meet the Team” series, we hear from Yuki Higa, a Process Engineer at Antheia. Read on to learn about...
Antheia
- Nov 16, 2020
Meet the Team – Our RA, Cat Cleto
We’re excited for the next interview in our “Meet the Team” series! We hear from Cat Cleto, a Fermentation Research Associate, on her...
Christina Smolke
- Oct 13, 2020
Antheia at SynBioBeta 2020
Earlier this month, my cofounder Kristy Hawkins and I presented at SynBioBeta 2020, the flagship conference for the synthetic biology...
Antheia
- Oct 6, 2020
Meet the Team - Our Scientist, Ken Takeoka
As a part of our new “Meet the Team” series, we hear from Ken Takeoka, Antheia’s very first employee and a Scientist III. Read on to...
Christina Smolke
- Sep 2, 2020
A Milestone for Drug Manufacturing and Synthetic Biology: Stanford Research Published in Nature
It’s a momentous day for my research team at Stanford University. Today, we’ve announced a new paper published in Nature that describes...
Christina Smolke
- Aug 20, 2020
Three plant-based pharmaceuticals: taxol, scopolamine and buprenorphine
Over the last 150 years, the pharmaceutical industry has focused on decoupling the production of medicinal compounds from their sources...